Capital Fund Management S.A. Abbott Laboratories Put Options Transaction History

Capital Fund Management S.A.

$36 Billion
Q3 2024

Put Options

26 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $2.74 Million - $3.24 Million	-27,400 Reduced 18.0%	124,800 $14.2 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $11 Million - $12.3 Million	-109,100 Reduced 41.75%	152,200 $15.8 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $12.5 Million - $13.8 Million	-114,500 Reduced 30.47%	261,300 $29.7 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $21.8 Million - $26.7 Million	-241,900 Reduced 39.16%	375,800 $41.4 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $28.9 Million - $34.7 Million	302,800 Added 96.16%	617,700 $59.8 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $27.5 Million - $30.7 Million	-273,000 Reduced 46.44%	314,900 $34.3 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $37.7 Million - $44.3 Million	389,000 Added 195.58%	587,900 $59.5 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $2.18 Million - $2.55 Million	-22,900 Reduced 10.32%	198,900 $21.8 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $21.5 Million - $24.8 Million	221,800 New	221,800 $21.5 Billion
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $5.26 Million - $6.41 Million	-46,100 Reduced 57.13%	34,600 $4.1 Million
Q4 2021 Feb 10, 2022	SELL	$115.53 - $141.46 $8.69 Million - $10.6 Million	-75,200 Reduced 48.24%	80,700 $11.4 Million
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $10.7 Million - $12.6 Million	101,500 Added 186.58%	155,900 $18.1 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $2.93 Million - $3.45 Million	26,900 Added 97.82%	54,400 $6.52 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $325,500 - $354,702	3,100 Added 12.7%	27,500 $3.01 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $2.24 Million - $2.72 Million	24,400 New	24,400 $2.66 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $336,907 - $431,200	-4,400 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $565,380 - $826,740	-9,000 Reduced 67.16%	4,400 $347,000
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $3.16 Million - $3.52 Million	-40,300 Reduced 75.05%	13,400 $1.16 Million
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $867,504 - $940,644	10,600 Added 24.59%	53,700 $4.49 Million
Q2 2019 Aug 12, 2019	BUY	$72.88 - $85.0 $1.25 Million - $1.46 Million	17,200 Added 66.41%	43,100 $3.63 Million
Q1 2019 May 13, 2019	BUY	$66.22 - $80.06 $993,300 - $1.2 Million	15,000 Added 137.61%	25,900 $2.07 Million
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $426,140 - $482,755	6,500 Added 147.73%	10,900 $788,000
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $24,324 - $29,344	400 Added 10.0%	4,400 $323,000
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $16.8 Million - $19 Million	-297,900 Reduced 98.68%	4,000 $240,000
Q4 2017 Feb 09, 2018	SELL	$53.68 - $57.47 $2 Million - $2.14 Million	-37,300 Reduced 11.0%	301,900 $17.2 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $16.3 Million - $18.2 Million	339,200	339,200 $18.1 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.8 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.4 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.03 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.74 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.28 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account